YSB Inc (9885) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of YSB Inc stock HK$7.01, price HK$3.33, upside +110.8%, quality 53 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
YSB Inc
9885 · HKCheap (53% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
41‑month range HK$3.05 – HK$59.25 · fair‑value band HK$4.91 – HK$9.12 · the HK$3.33 price screens below the HK$7.01 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether YSB is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
Show moreShow less
The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system.
It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products.
Further, it provides medical testing services; logistics services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.
Stock analysis
YSB Inc (9885) currently trades at HK$3.33, while our model-based Fair Value estimate is HK$7.01, implying the stock looks roughly 53% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of HK$20.52 per share, and 20 of the 26 models we run sit above the HK$3.33 price.
Bear case: the Asset-Based group reads lowest at HK$1.51, and 6 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: HK$4.91 (bear) to HK$9.12 (bull), the price of HK$3.33 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
YSB Inc reported revenue of 21.0B CNY in FY2025 versus 10.1B CNY in FY2021, a compound +20.1%/yr. Reported net income was 153M CNY in FY2025.
Key figures
Market cap HK$2.3B (≈ $289M) Micro · P/E ratio 11.6 · P/S ratio 0.08 · Dividend yield 3.3% · Net margin 0.9% · Return on equity 7.9% · Return on assets (EBIT) −4.1% (5-year average) · Operating margin 0.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 25 out of 100 (low confidence).
What moves the price
The share trades about 57% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 25% fair-value upside, at 111%, 9885 screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 9885, get fair value alerts →
Compare YSB Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 52 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EV/EBITDA by industry
- Dividend yield by industry
- Stock screener with 62 metrics
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Al-Dawaa Medical Services Company 4163 | 37.30 SAR | 79.49 SAR | +113% | vs 9885 |
| JD Health International Inc 6618 | HK$40.66 | HK$75.64 | +86% | vs 9885 |
| Yifeng Pharmacy Chain Co 603939 | ¥25.48 | ¥40.59 | +59% | vs 9885 |
| Yixintang Pharmaceutical Group 002727 | ¥12.84 | ¥18.92 | +47% | vs 9885 |
| DaShenLin Pharmaceutical Group 603233 | ¥20.45 | ¥25.52 | +25% | vs 9885 |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥13.33 | ¥14.66 | +10% | vs 9885 |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.26 | ¥15.66 | +10% | vs 9885 |
| DocMorris AG DOCM | CHF 18.75 | CHF 15.17 | −19% | vs 9885 |
| ShuYu Civilian Pharmacy Corp 301017 | ¥13.72 | ¥5.91 | −57% | vs 9885 |
| Apotea AB APOTEA | kr 100.40 | kr 39.50 | −61% | vs 9885 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is YSB Inc (9885) overvalued or undervalued?
What is the fair value of 9885?
What is the quality score of 9885?
What is the price target for YSB Inc (9885)?
What is the YSB Inc stock forecast for 2026?
What is the revenue of YSB Inc (9885)?
Does YSB Inc pay a dividend?
How much is the dividend of YSB Inc (9885) and when is the ex-dividend date?
What growth is priced into YSB Inc (9885)?
What discount rate (WACC) does the fair value of 9885 use?
What is a reverse DCF?
How much growth has YSB Inc (9885) delivered so far?
How fast is the sector of YSB Inc (9885) growing?
What is the free cash flow yield of YSB Inc (9885)?
What is the intrinsic value of YSB Inc (9885)?
Is YSB Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 9885?
How much is YSB Inc worth?
What do the bullish and bearish scenarios say about 9885?
What is the P/E ratio of 9885?
How solid is the balance sheet of YSB Inc (9885)?
How far is 9885 from its 52-week high?
Which stocks are comparable to YSB Inc?
Is YSB Inc stock attractive at the current price?
How is the fair value of 9885 calculated?
Is it still worth investing in stocks now?
What is the share price of YSB Inc (9885)?
What should I pay attention to with YSB Inc right now?
Key figures of YSB Inc
How large is the market capitalisation of YSB Inc (9885)?
What is the P/S ratio of YSB Inc (9885)?
What is the dividend yield of YSB Inc (9885)?
What is the net margin of YSB Inc (9885)?
What is the return on equity of YSB Inc (9885)?
What is the EBIT return on assets of YSB Inc (9885)?
What is the operating margin of YSB Inc (9885)?
How fast is revenue growing at YSB Inc (9885)?
How fast are earnings growing at YSB Inc (9885)?
How much net debt does YSB Inc (9885) carry?
Watch YSB Inc in the live analysis
One click puts YSB Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.